HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says
In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants
Intramural Clinical Research Could Lose “Critical Mass” – Chabner
NCI May Ask Grantees To Assume Additional Services, Broder Says
DCT Board Approves New RFA For Aids Clinical Trials Groups
Letters: Two NCI Pamphlets On Mammography Are Inaccurate
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









